Work

Drug delivery agent that acts as a drug for synergistic activity

Year: 2025

Type: article

Abstract: results are mixed, the overall results suggest the potential of a new strategy where both drug and delivery agent actively target a disease pathology.

Source: iScience

DOI: 10.1016/j.isci.2025.112890

Authors: Ke Li, Ullas V. Chembazhi, Sarah B. Krueger, Zachary Dewald, Junfeng Chen, Yugang Bai, Dongwook Kim, Amie N. Lanzendorf, Philip A. Kocheril, Jie Chen, Auinash Kalsotra, Steven C. Zimmerman

Institutions: University of Illinois Urbana-Champaign, Mount St. Mary's University, Chan Zuckerberg Biohub Chicago, Carl R. Woese Institute for Genomic Biology, Ben-Gurion University of the Negev

Language: English

Topic: Nanoparticle-Based Drug Delivery

Subfield: Biomaterials

Field: Materials Science

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,240

Funders: National Science Foundation, Muscular Dystrophy Association, University of Florida, National Institutes of Health, University of California, San Diego, National Heart, Lung, and Blood Institute, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Science Foundation Graduate Research Fellowship Program

Awards: G2056264283, Post-transcriptional mechanisms of gene regulation in cardiac cell growth and development, G4495300808, G7104136687, Small Molecule Approaches to Targeting the DNA and RNA in Myotonic Dystrophy, Mechanisms of fatty liver disease and impaired drug metabolism in DM1, G9000031247

OpenAlex ID: W4411273918

FWCI: 0.368

Cites: 56

Cited by: 2

Related to: 10